Growth Metrics

Conmed (CNMD) Accounts Payables (2016 - 2026)

Conmed filings provide 17 years of Accounts Payables readings, the most recent being $105.4 million for Q1 2026.

  • On a quarterly basis, Accounts Payables rose 10.12% to $105.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $105.4 million, a 10.12% increase, with the full-year FY2025 number at $93.6 million, down 8.41% from a year prior.
  • Accounts Payables hit $105.4 million in Q1 2026 for Conmed, up from $93.6 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $107.1 million in Q3 2025 to a low of $67.5 million in Q1 2022.
  • Median Accounts Payables over the past 5 years was $93.6 million (2025), compared with a mean of $89.8 million.
  • Biggest five-year swings in Accounts Payables: skyrocketed 59.3% in 2022 and later dropped 8.41% in 2025.
  • Conmed's Accounts Payables stood at $73.4 million in 2022, then increased by 20.21% to $88.2 million in 2023, then rose by 15.9% to $102.2 million in 2024, then decreased by 8.41% to $93.6 million in 2025, then increased by 12.57% to $105.4 million in 2026.
  • The last three reported values for Accounts Payables were $105.4 million (Q1 2026), $93.6 million (Q4 2025), and $107.1 million (Q3 2025) per Business Quant data.